Previous studies demonstrated that, in rheumatoid arthritis synovial tissue, 1,25-dihydroxyvitamin D3 may downregulate pro-inflammatory cytokine production in activated macrophages, decreasing aromatase activity, especially in presence of an estrogenic milieu [24]. The gene discussed is CYP19A1; the disease is rheumatoid arthritis.